Unpredictable hematologic toxicity of weekly ddmp.
作者信息
Hansen M, Lau M E, Hansen H H
出版信息
Cancer Treat Rep. 1978 May;62(5):849-50.
PMID:306873
Abstract
摘要
相似文献
1
Unpredictable hematologic toxicity of weekly ddmp.每周一次剂量密集甲氨蝶呤的不可预测血液学毒性。
Cancer Treat Rep. 1978 May;62(5):849-50.
2
Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.亚叶酸解救的美托普林用于晚期结直肠癌患者的II期评估。
Cancer Clin Trials. 1981 Fall;4(3):281-3.
3
An experimentally designed high dose simultaneous combination of a diaminopyrimidine and folinic acid for the treatment of human malignancies.一种经实验设计的二氨基嘧啶与亚叶酸高剂量同时联合用药方案，用于治疗人类恶性肿瘤。
Eur J Cancer Clin Oncol. 1981 Aug;17(8):857-61. doi: 10.1016/0014-2964(81)90305-4.
4
5
Phase I trial of metoprine in patients with advanced cancer.
Cancer Treat Rep. 1980 Aug-Sep;64(8-9):951-6.
6
Phase II evaluation of metoprine in patients with non-small-cell lung carcinoma.美托普林用于非小细胞肺癌患者的II期评估。
Cancer Clin Trials. 1981 Fall;4(3):273-6.
7
Initial clinical experience with a simultaneous combination of 2,4-diamino-5(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) with folinic acid.
Cancer Chemother Pharmacol. 1978;1(2):101-5. doi: 10.1007/BF00254043.
8
Phase II clinical trial of DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine) and folinic acid (CF) in solid tumors.DDMP（2,4-二氨基-5-（3',4'-二氯苯基）-6-甲基嘧啶）与亚叶酸（CF）联合用于实体瘤的II期临床试验。
Cancer Chemother Pharmacol. 1981;6(1):81-4. doi: 10.1007/BF00253014.
9
Experimental chemotherapy with 5-arylpyrimidine antifolates: preliminary studies on toxicity and responsiveness of sarcoma 180 to DDMP (NSC-19494) and DDMP with citrovorum factor (NSC-3590).5-芳基嘧啶抗叶酸剂的实验性化疗：肉瘤180对DDMP（NSC-19494）及DDMP与甲酰四氢叶酸（NSC-3590）的毒性和反应性的初步研究。
Cancer Treat Rep. 1976 May;60(5):547-53.
10
Phase II study of diamino-dichlorophenyl-methylpyrimidine (DDMP) with folinic acid (CF) protection and rescue.二氨基二氯苯基甲基嘧啶（DDMP）联合亚叶酸钙（CF）保护与解救的II期研究。
Eur J Cancer (1965). 1980 Sep;16(9):1243-9. doi: 10.1016/0014-2964(80)90184-x.
Zotero 插件